237 related articles for article (PubMed ID: 21091667)
41. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.
Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME
Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory autoantibody to a conformational epitope of the pyruvate dehydrogenase complex, the major autoantigen in primary biliary cirrhosis.
Rowley MJ; McNeilage LJ; Armstrong JM; Mackay IR
Clin Immunol Immunopathol; 1991 Sep; 60(3):356-70. PubMed ID: 1713816
[TBL] [Abstract][Full Text] [Related]
43. [The association between autoantibodies to enzyme and diseases--with special reference to antibodies to pyruvate dehydrogenase complex (PDH)].
Moteki S; Amaki S; Nakano E
Rinsho Byori; 1998 Apr; 46(4):317-23. PubMed ID: 9594621
[TBL] [Abstract][Full Text] [Related]
44. Immunoreactivity of porcine heart dihydrolipoamide acetyl- and succinyl-transferases (PDC-E2, OGDC-E2) with primary biliary cirrhosis sera: characterization of the autoantigenic region and effects of enzymatic delipoylation and relipoylation.
Koike K; Ishibashi H; Koike M
Hepatology; 1998 Jun; 27(6):1467-74. PubMed ID: 9620315
[TBL] [Abstract][Full Text] [Related]
45. Cellular localization, expression, and structure of the nuclear dot protein 52.
Sternsdorf T; Jensen K; Züchner D; Will H
J Cell Biol; 1997 Jul; 138(2):435-48. PubMed ID: 9230084
[TBL] [Abstract][Full Text] [Related]
46. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
[TBL] [Abstract][Full Text] [Related]
47. Autoantigens in primary biliary cirrhosis.
Jones DE
J Clin Pathol; 2000 Nov; 53(11):813-21. PubMed ID: 11127262
[TBL] [Abstract][Full Text] [Related]
48. Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210.
Nickowitz RE; Worman HJ
J Exp Med; 1993 Dec; 178(6):2237-42. PubMed ID: 7504063
[TBL] [Abstract][Full Text] [Related]
49. Autoimmune tests in primary biliary cirrhosis.
Strassburg CP; Manns MP
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):585-99. PubMed ID: 10976016
[TBL] [Abstract][Full Text] [Related]
50. GW/P-bodies and autoimmune disease.
Bloch DB; Nobre RA; Yang WH
Adv Exp Med Biol; 2013; 768():61-70. PubMed ID: 23224965
[TBL] [Abstract][Full Text] [Related]
51. Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis.
Migliaccio C; Nishio A; Van de Water J; Ansari AA; Leung PS; Nakanuma Y; Coppel RL; Gershwin ME
J Immunol; 1998 Nov; 161(10):5157-63. PubMed ID: 9820485
[TBL] [Abstract][Full Text] [Related]
52. Immunoblotting as a confirmatory test for antimitochondrial antibodies in primary biliary cirrhosis.
Provenzano G; Diquattro O; Craxì A; Almasio P; Pinzello G; Marino L; Fiorentino G; Rinaldi F; Pagliaro L
Gut; 1993 Apr; 34(4):544-8. PubMed ID: 8491404
[TBL] [Abstract][Full Text] [Related]
53. Nuclear envelope protein autoantibodies in primary biliary cirrhosis.
Courvalin JC; Worman HJ
Semin Liver Dis; 1997 Feb; 17(1):79-90. PubMed ID: 9089913
[TBL] [Abstract][Full Text] [Related]
54. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.
Nakamura M; Kondo H; Mori T; Komori A; Matsuyama M; Ito M; Takii Y; Koyabu M; Yokoyama T; Migita K; Daikoku M; Abiru S; Yatsuhashi H; Takezaki E; Masaki N; Sugi K; Honda K; Adachi H; Nishi H; Watanabe Y; Nakamura Y; Shimada M; Komatsu T; Saito A; Saoshiro T; Harada H; Sodeyama T; Hayashi S; Masumoto A; Sando T; Yamamoto T; Sakai H; Kobayashi M; Muro T; Koga M; Shums Z; Norman GL; Ishibashi H
Hepatology; 2007 Jan; 45(1):118-27. PubMed ID: 17187436
[TBL] [Abstract][Full Text] [Related]
55. Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis.
Mattalia A; Lüttig B; Rosina F; Leung PS; Van de Water J; Bauducci M; Ciancio A; Böker KH; Worman H; Cooper RL; Manns M; Ansari A; Rizzetto M; Gershwin ME
J Autoimmun; 1997 Oct; 10(5):491-7. PubMed ID: 9376077
[TBL] [Abstract][Full Text] [Related]
56. An SNP in the trinucleotide repeat region of the TNRC6A gene maps to a major TNGW1 autoepitope in patients with autoantibodies to GW182.
Moser JJ; Chan EK; Fritzler MJ
Adv Exp Med Biol; 2013; 768():243-59. PubMed ID: 23224974
[TBL] [Abstract][Full Text] [Related]
57. Autoantibodies by line immunoassay in patients with primary biliary cirrhosis.
Saito H; Takahashi A; Abe K; Okai K; Katsushima F; Monoe K; Kanno Y; Ohira H
Fukushima J Med Sci; 2012; 58(2):107-16. PubMed ID: 23237866
[TBL] [Abstract][Full Text] [Related]
58. Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182.
Eystathioy T; Chan EK; Takeuchi K; Mahler M; Luft LM; Zochodne DW; Fritzler MJ
J Mol Med (Berl); 2003 Dec; 81(12):811-8. PubMed ID: 14598044
[TBL] [Abstract][Full Text] [Related]
59. Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope.
Wesierska-Gadek J; Hohenauer H; Hitchman E; Penner E
Hum Antibodies Hybridomas; 1996; 7(4):167-74. PubMed ID: 9140728
[TBL] [Abstract][Full Text] [Related]
60. The pyruvate dehydrogenase complex as a target autoantigen in primary biliary cirrhosis.
Nishio A; Coppel R; Ishibashi H; Gershwin ME
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):535-47. PubMed ID: 10976013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
